dna microarray-based breast cancer prognosis test mammaprint (Agendia BV)
90
Structured Review
Agendia BV
dna microarray-based breast cancer prognosis test mammaprint
Dna Microarray Based Breast Cancer Prognosis Test Mammaprint, supplied by Agendia BV, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+microarray+testing/microarray+based+mammaprint/pm18534094-68-9-10
Average 90 stars, based on 1 article reviews
Dna Microarray Based Breast Cancer Prognosis Test Mammaprint, supplied by Agendia BV, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+microarray+testing/microarray+based+mammaprint/pm18534094-68-9-10
Average 90 stars, based on 1 article reviews
dna microarray-based breast cancer prognosis test mammaprint - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Modern Methods for Breast Cancer Diagnosis and Classification: A Current Update Article Snippet: The incidence of cancer-related deaths worldwide has increased by 66% since 1960, according to the International Agency for Research on Cancer (IARC).. A breast cancer diagnosis is predicted to occur in one in eight women in the US alone at some point in their lifetime.. A BC diagnosis is typically made using high-end molecular bioimaging, ultrasound, and mammography. Article Title: Prognostic Value of IGF2 mRNA-Binding Protein 3 (IGF2BP3) Intratumoral Expression in Melanoma Patients at the Time of Diagnosis: Comparative Analysis of RT-qPCR Versus Immunohistochemistry. Article Snippet: Examples of these are the microarray-based clinical tests, such as Article Title: Tumour-Infiltrating Immune Cell-Based Subtyping and Signature Gene Analysis in Breast Cancer Based on Gene Expression Profiles Article Snippet: Three multigene expression assays (PCR-based OncotypeDX (Genomic Health Inc., Redwood City, CA, USA) , , Article Title: Prognostic Value of IGF2 mRNA-Binding Protein 3 (IGF2BP3) Intratumoral Expression in Melanoma Patients at the Time of Diagnosis: Comparative Analysis of RT-qPCR Versus Immunohistochemistry Article Snippet: Examples of these are the microarray-based clinical tests, such as Article Title: MRI-Based Model for Personalizing Neoadjuvant Treatment in Breast Cancer. Article Snippet: To be eligible for enrollment, patients with HR+/HER2− breast cancer also need to be at high risk for recurrence based on the Article Title: Considering adjuvant therapy for stage II melanoma Article Snippet: GEP testing for patients with breast cancer (Oncotype [Genomic Health Inc], Microarray:Article Title: Microarray and RNA in situ hybridization assay for recurrence risk markers of breast carcinoma and ductal carcinoma in situ : evidence supporting the use of diverse pathways panels Article Snippet: .. Available predictive tests include the Gene Expression:Article Title: Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling Article Snippet: .. In this scenario, personalized prediction tools such as |
